ZEISS Launches MyoCare Lenses in Sri Lanka to Safeguard Children’s Vision

ZEISS, a global leader and a pioneer of science in optics and optoelectronics, has announced the launch of its ZEISS MyoCare lenses in Sri Lanka, bringing advanced myopia management solutions for children across the country. 

The launch event, ‘ZEISS Innovation Summit’ took place at the Cinnamon Life, where more than 200 leading opticians, hospital representatives, and eye care professionals gathered to witness the future of vision technology.

Designed specifically for children, ZEISS MyoCare lenses help slow down the progression of myopia while providing clear, comfortable vision. With the rising prevalence of myopia among young patients in Sri Lanka and globally, this introduction marks a significant step in making world-class eye care solutions more accessible and affordable.

The initiative has been rolled out in partnership with Wickramarachchi Opticians, one of Sri Lanka’s most trusted names in vision care. Together, ZEISS and Wickramarachchi aim to expand access to advanced technologies that address the urgent need for early intervention in children’s eye health.

“Protecting children’s eyesight early is one of the most important investments we can make in their future. Wickramarachchi Opticians has been a trusted name in Sri Lanka for generations, and our partnership with ZEISS reflects our shared belief that advanced technology should be within everyone’s reach - without compromising on quality,” said Liza Wickramarachchi, Managing Director, Wickramarachchi Opticians.

The ZEISS Innovation Summit also showcased their latest innovations in precision optics, alongside a style-forward fashion presentation of the new Ross frames and sunglasses collection - blending technology, trust, and contemporary eyewear trends.

With the launch of ZEISS MyoCare lenses, Sri Lanka is taking a bold step forward in combating childhood myopia and ensuring that the next generation has access to the best possible vision care.

Photo Caption

From left to right: Khushi Khan - Marketing Specialist, ZEISS Vision Care, Carl ZEISS India; Rupam Sinha - Myopia Management Lead, ZEISS Vision Care, Carl ZEISS India; Mihira Wickramarachchi - President, Wickramarachchi Opticians & Hearing Care; Abir Chandra - Business Head – Vision Division, SAARC Countries, Carl ZEISS India; and Jayanta Chakraborty - Head of Product & Training, SAARC Countries, Carl ZEISS India.

About ZEISS Group

ZEISS is an internationally leading technology enterprise operating in optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totalling 10.9 billion euros in its four segments: Semiconductor Manufacturing Technology, Industrial Quality and Research, Medical Technology, and Consumer Markets.

For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products, including eyeglass lenses, camera lenses, and binoculars.

With a portfolio aligned with future growth areas like digitalisation, healthcare and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company's significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS's technology and market leadership. ZEISS invests 15 per cent of its revenue in research and development – this high level of expenditure has a long tradition at ZEISS and is also an investment in the future.

With approximately 46,485 employees, ZEISS is active globally in nearly 50 countries, operating around 30 production sites, 60 sales and service companies, and 27 research and development facilities. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany, dedicated to the promotion of science, is the sole owner of Carl Zeiss AG, the holding company.

Further information at www.zeiss.com